Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: A multicentre, open-label, phase 2 trial
Academic Article
Article
Overview
MeSH Major
-
Carcinoma, Non-Small-Cell Lung
-
Lung Neoplasms
abstract
-
National Cancer Institute and CycleforSurvival Fund, Memorial Sloan-Kettering Cancer Center.
publication date
published in
Research
keywords
Identity
Digital Object Identifier (DOI)
-
10.1016/S1470-2045(13)70049-4
PubMed ID
Additional Document Info
has global citation frequency
start page
end page
volume
number